|View printer-friendly version|
|Array BioPharma to Present at the Thomas Weisel Partners Healthcare Conference 2005|
BOULDER, Colo., Aug. 31 /PRNewswire-FirstCall/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Thomas Weisel Partners Healthcare Conference on September 9 in Boston. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.
Event: Thomas Weisel Partners Healthcare Conference
Array BioPharma is a biopharmaceutical company focused on the discovery, development and commercialization of orally active drugs to address significant unmet medical needs. Our proprietary drug development pipeline is primarily focused on the treatment of cancer and inflammatory disease and includes several small molecule drug candidates that are designed to regulate targets in therapeutically important biologic pathways. In addition, leading pharmaceutical and biotechnology companies access our drug discovery technologies and expertise through collaborations to design, create, optimize and evaluate drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.
SOURCE Array BioPharma Inc.